AURKA and endometrial cancer: They proposed that the jagged canonical Notch ligand 2 (JAG2), Aurora kinase A (AURKA), phosphoglycerate kinase 1 (PGK1), and hypoxanthine phosphoribosyltransferase 1 (HRPT1) could be used independently as diagnostic, prognostic, or treatment biomarkers in endometrial cancer [16].